Overview of reported diseased DADA2 carriers in literature
| Study | Age at onset (years) | ADA2 genotype | Clinical phenotype | ADA2 activity | Treatment |
|---|---|---|---|---|---|
| Zhou et al. (1) | Adulthood | p.Y453C/WT | Small vessel ischemic stroke | Unknown | Unknown |
| Zhou et al. (1) | Adulthood | p.Y453C/WT | Hypertension, small vessel ischemic stroke | Unknown | Warfarin |
| Rama et al. (130) | 5 | p.G47R/WT | Recurrent fever, elevated CRP levels, cephalgia, arthralgia, myalgia, papular rash with pruritic and GI manifestations | Carrier range | Unknown |
| Nihira et al. (120) | 10 | p.E328K/WT | Fever, intracranial hemorrhage, cerebral infarction, livedo racemosa, splenomegaly, and renal infarction | Low | Infliximab and SCIG replacement |
| Nihira et al. (120) | 12 | p.E328K/WT | Diplopia, memory disturbances, livedo racemosa, and renal infarction | Low | Infliximab and SCIG replacement |
| Schnappauf et al. (106) | Adulthood | p.Y453C/WT | PAN with fever, cutaneous ulcers, and neuropathy | High carrier range | Unknown |
| Moi et al. (131) | Childhood | p.R169Q/WT | Arthritis, recurrent infections, and common variable immunodeficiency | Carrier range | IVIG replacement |
| Celikel et al. (134) | 1.5 | p.G47R/WT | Recurrent fever, elevated CRP levels, and anemia | Unknown | Etanercept |
| Izumo et al. (132) | 9 | p.F355L/p.Y453C | Elevated CRP levels, livedo, and multiple cerebral infarctions | Carrier range | Infliximab |
| Pulvirenti et al. (129) | 12 | p.Y453C/WT | Fever, skin rash, hypogammaglobulinemia, and lymphadenitis | Unknown | No treatment |
| Yilmaz et al. (133) | 20 | p.R49Afs*13/WT | Crohn’s disease | Carrier range | Surgery plan |
| Study | Age at onset (years) | ADA2 genotype | Clinical phenotype | ADA2 activity | Treatment |
|---|---|---|---|---|---|
| Zhou et al. ( | Adulthood | p.Y453C/WT | Small vessel ischemic stroke | Unknown | Unknown |
| Zhou et al. ( | Adulthood | p.Y453C/WT | Hypertension, small vessel ischemic stroke | Unknown | Warfarin |
| Rama et al. ( | 5 | p.G47R/WT | Recurrent fever, elevated CRP levels, cephalgia, arthralgia, myalgia, papular rash with pruritic and GI manifestations | Carrier range | Unknown |
| Nihira et al. ( | 10 | p.E328K/WT | Fever, intracranial hemorrhage, cerebral infarction, livedo racemosa, splenomegaly, and renal infarction | Low | Infliximab and SCIG replacement |
| Nihira et al. ( | 12 | p.E328K/WT | Diplopia, memory disturbances, livedo racemosa, and renal infarction | Low | Infliximab and SCIG replacement |
| Schnappauf et al. ( | Adulthood | p.Y453C/WT | PAN with fever, cutaneous ulcers, and neuropathy | High carrier range | Unknown |
| Moi et al. ( | Childhood | p.R169Q/WT | Arthritis, recurrent infections, and common variable immunodeficiency | Carrier range | IVIG replacement |
| Celikel et al. ( | 1.5 | p.G47R/WT | Recurrent fever, elevated CRP levels, and anemia | Unknown | Etanercept |
| Izumo et al. ( | 9 | p.F355L/p.Y453C | Elevated CRP levels, livedo, and multiple cerebral infarctions | Carrier range | Infliximab |
| Pulvirenti et al. ( | 12 | p.Y453C/WT | Fever, skin rash, hypogammaglobulinemia, and lymphadenitis | Unknown | No treatment |
| Yilmaz et al. ( | 20 | p.R49Afs*13/WT | Crohn’s disease | Carrier range | Surgery plan |
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.